Cheapest Tirzepatide Online 2026: From $119/mo — Every Verified Price

The floor: $119/mo, but read the condition

Compounded tirzepatide runs 30–70% pricier than semaglutide at the same provider — the dual GIP/GLP-1 molecule costs more to source. The verified floor in September 2026 is $119/month, reachable two different ways with very different risk profiles. For the broader market, start with our GLP-1 Price Index; this page is the tirzepatide-only deep dive.

Verified compounded tirzepatide prices — September 2026

The $119 tie: SnagRx vs Embody

Both hit $119/mo — but SnagRx's rate is locked for life on a plan structure, while Embody's requires $1,428 upfront and reprices at renewal. Head-to-head detail: Embody vs SnagRx. The short version: SnagRx is the better 12-month contract; Embody's month-to-month $129 is the cheapest no-commitment entry.

When the brand version wins: Zepbound at $349

Above roughly $250/mo compounded, brand Zepbound becomes the rational choice: LillyDirect sells single-dose vials at $349/mo self-pay — FDA-approved, no insurance gymnastics. At ShedRx's $299 month-to-month or MEDVi's $399, you're paying brand prices for a compounded product. The crossover math:

• Under $150 compounded → meaningful savings vs $349 Zepbound; the trade (non-FDA-approved finished product) is defensible
• $200–$250 compounded → gray zone; pay only if you need formats Zepbound doesn't offer (oral tablets via Synergy Rx)
• $300+ compounded → buy the brand or rethink the provider

Tirzepatide-specific traps

• Dose-scaled pricing: some providers charge more at 10mg+ — get the escalation policy in writing before titrating
• Intro-only rates: MEDVi's $279 and Yucca's $258 are month-1 promos; ongoing is $399/$325
• "Dual agonist" markup games: the tirz premium should be ~30–70% over the same provider's sema — if it's 3x, the provider is padding
• Semaglutide may be enough: if you haven't tried sema, the $50–$150/mo delta buys you a cheaper trial first — switch only if it plateaus

Bottom line

Best value: SnagRx $119 locked for commitment-ready buyers, Embody $129 month-to-month for trial runs, Trimi $125 for 50-state coverage. Best safety: Zepbound $349 at LillyDirect once compounded quotes approach it. Everything else in the table is a version of paying more for the same molecule.

Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. Compounded tirzepatide is not FDA-approved as a finished product and requires a prescription. Pricing verified September 2026.